BioCatalyst

NRC-2694-A, Paclitaxel — catalyst calendar

1 verified catalyst event(s) referencing NRC-2694-A, Paclitaxel, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-30
in 3mo
ESTIMATED
 READOUT
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With
Phase 2 · Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
 NATCO Pharma Ltd. NRC-2694-A, Paclitaxel ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.